Drug Shortage Report for HIBERIX
Report ID | 29521 |
Drug Identification Number | 02239200 |
Brand name | HIBERIX |
Common or Proper name | Haemophilus influenzae type b (Hib) conjugate vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE |
Strength(s) | 10MCG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's |
ATC code | J07AG |
ATC description | BACTERIAL VACCINES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-11-16 |
Estimated end date | 2017-12-07 |
Actual end date | 2017-12-04 |
Shortage status | Resolved |
Updated date | 2017-12-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-17 | English | Compare |
v2 | 2017-11-17 | French | Compare |
v3 | 2017-12-01 | English | Compare |
v4 | 2017-12-01 | French | Compare |
v5 | 2017-12-06 | English | Compare |
v6 | 2017-12-06 | French | Compare |
Showing 1 to 6 of 6